Abstract:The accumulation of senescent cells, a hallmark phenotype of aging tissues, elevates the risk of cardiovascular disease with age. Our prior studies have illustrated a crucial role played by senescent cells in promoting coagulation during murine atherosclerosis through the senescence-associated secretory phenotype (SASP). To explore the heterogeneity of senescent vascular cells in thrombotic vascular diseases and identify potential druggable pathways to counter senescence, we utilized the senescence reporter mouse p16TdTomato+/-, which was injected with an adeno-associated virus expressing Proprotein Convertase Subtilisin/Kexin type 9 to induce atherosclerosis when subjected to a high-fat diet (HFD). In a subset of HFD mice, some were left untreated, while others were treated with senolytic drug ABT-737 to selectively eliminate senescent cells. Aortas from ABT-737-treated mice exhibited increased collagen deposition and reduced arterial stiffness. Paired with pseudo-bulk RNA-sequencing analysis, we observed that HFD-induced extracellular matrix (ECM) remodeling genes were diminished by ABT-737, suggesting that ECM-platelet interactions may be influenced by senescence. Single-cell RNA-sequencing analysis from aortas identified 28 distinct cell clusters. Utilizing Gene Set Enrichment Analysis with the SenMayo and CellAge panels, we identified four cell clusters exhibiting increased senescent features that were mitigated by ABT-737. These included two VSMC clusters, fibroblasts, and neutrophil-like cells. Unbiased subclustering of potentially senescent clusters revealed a small population of cells enriched with HFD and reduced by ABT-737, confirming their senescent nature. In the most abundant cluster, Spp1 and Serpine2 strongly represented the senescent VSMC subpopulation, enriched for TGFβ signaling, ECM remodeling, and coagulation cascade genes. Further, we validated these findings through spatial transcriptomics and single-molecule FISH of brachiocephalic arteries from atherosclerotic mice and atherosclerotic mice depleted of senescent cells. Our results reveal a novel transcriptomic signature for senescent vascular cells that holds potential for therapeutic targeting in age-related vascular diseases.

Impaired immune surveillance accelerates accumulation of senescent cells and aging

Senescent cells: SASPected drivers of age-related pathologies

An aged immune system drives senescence and ageing of solid organs

Senolytics improve physical function and increase lifespan in old age

p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells

CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice

Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases

Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases

The bystander effect contributes to the accumulation of senescent cells in vivo

Cellular senescence: the good, the bad and the unknown

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

Senescent glia link mitochondrial dysfunction and lipid accumulation

Abstract 100: Omics Strategies To Identify Senescent Cells Mediating Extracellular Matrix Remodeling During Vascular Disease

T-cell immunity against senescence: potential role and perspectives

Senescent Cell-Secreted Netrin-1 Modulates Aging-Related Disorders by Recruiting Sympathetic Fibers

Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria

Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging

[Pathophysiological implications of cellular senescence and prospects for novel anti-aging drugs]

Role of immune cells in the removal of deleterious senescent cells